Alexander J Sutton1, Nicola J Cooper, Keith R Abrams
1Department of Health Sciences, University of Leicester, 22-28 Princess Road West, Leicester LE1 6TP, United Kingdom. ajs22@le.ac.uk
Individualized treatment decisions require evaluating net clinical benefit. This study reanalyzes warfarin use in atrial fibrillation, questioning prior conclusions due to data limitations but offering a Bayesian framework for personalized patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: